Dr. Susan Chi, MD
Claim this profileDana-Farber Cancer Institute
Expert in Brain Tumor
Expert in Cerebral Gliomas
29 reported clinical trials
62 drugs studied
About Susan Chi, MD
Education:
- Obtained MD from Harvard Medical School in 2007.
- Completed Residency in Internal Medicine at Brigham and Women's Hospital (2007-2010).
- Undertook Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute/Brigham and Women's Hospital (2010-2013).
Experience:
- Serving as an attending physician at Dana-Farber Cancer Institute.
- Holds the position of Assistant Professor of Medicine at Harvard Medical School.
Area of expertise
1Brain Tumor
Global LeaderH3.3K27M positive
IDH positive
Stage I
2Cerebral Gliomas
Global LeaderStage I
Stage II
IDH positive
Affiliated Hospitals
Clinical Trials Susan Chi, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting1 award Phase 2
More about Susan Chi, MD
Clinical Trial Related5 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Susan Chi, MD has experience with
- Nivolumab
- Temozolomide
- Radiation Therapy
- Ipilimumab
- Etoposide
- Cyclophosphamide
Breakdown of trials Susan Chi, MD has run
Brain Tumor
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
- Avapritinib for Pediatric Solid Cancers
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Cerebral Gliomas
- Selumetinib vs. Chemotherapy for Brain Cancer
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
- Ribociclib + Everolimus for Brain Tumors
Diffuse Intrinsic Pontine Glioma
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
- Ribociclib + Everolimus for Brain Tumors
Brain Cancer
- Selumetinib vs. Chemotherapy for Brain Cancer
- REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
- Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Chi, MD specialize in?
Susan Chi, MD focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are IDH positive.
Is Susan Chi, MD currently recruiting for clinical trials?
Yes, Susan Chi, MD is currently recruiting for 19 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Susan Chi, MD has studied deeply?
Yes, Susan Chi, MD has studied treatments such as Nivolumab, Temozolomide, Radiation Therapy.
What is the best way to schedule an appointment with Susan Chi, MD?
Apply for one of the trials that Susan Chi, MD is conducting.
What is the office address of Susan Chi, MD?
The office of Susan Chi, MD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.